Urinary Function

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

C
ColoplastAustralia - Mulgrave
1 program
Coloplast SpeediCath CH12 standard male intermittent catheterN/A1 trial
Active Trials
NCT05560594CompletedEst. Aug 2022

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
ColoplastColoplast SpeediCath CH12 standard male intermittent catheter

Clinical Trials (1)

NCT05560594ColoplastColoplast SpeediCath CH12 standard male intermittent catheter

Investigate Bladder and Prostate During Emptying With Intermittent Catheter

Start: Feb 2022Est. completion: Aug 2022
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space